Sevara Khudayarova

9 ta ish

Toshkent Tibbiyot Akademiyasi

1. Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

   Sevara Khudayarova, G. Rakhmatullaeva, K. Khalimova

   MaqolaNeurological Disorders and TreatmentsParkinsonism & Related Disorders20200 iqtibos

   ABIABI:AkademIndex/2020.article.004047

2. Sleep disorders in patients with chronic kidney disease

   Sevara Khudayarova, Gulnara Rakhatullaeva

   MaqolaHealth and Lifestyle StudiesJournal of the Neurological Sciences20210 iqtibos

   ABIABI:AkademIndex/2021.article.008820

3. FEATURES OF COGNITIVE DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND THE EFFECT OF CYSTATIN C ON IT DEPENDING ON THE STAGE OF THE DISEASE

   Sevara Khudayarova

   MaqolaOAOchiq kirishNeurological Disorders and TreatmentsFrontline Medical Sciences and Pharmaceutical Journal20220 iqtibos

   ABIABI:AkademIndex/2022.article.003846

4. Cognitive disorders in patients with chronic kidney disease(CKD) and its relationship with the concentration in the blood of the biomarker of kidney damage cystatin C

   Sevara Khudayarova, Gulnara Rakhmatullaevna

   MaqolaOAOchiq kirishNeurological Disorders and TreatmentsJournal of the Neurological Sciences20230 iqtibos

   ABIABI:AkademIndex/2023.article.012322

5. The role of brain-derived neurotrophic factor during Parkinson's disease

   Bahtigul Holmuratova, Nilufar Rashidova, K. Khalimova +1

   MaqolaAutism Spectrum Disorder ResearchParkinsonism & Related Disorders20240 iqtibos

   ABIABI:AkademIndex/2024.article.005937

6. Examination of cognitive function in Parkinson's disease patients with chronic kidney disease

   Sevara Khudayarova, G.K. Rakhmatullayeva, Bahtigul Holmuratova

   MaqolaDementia and Cognitive Impairment ResearchParkinsonism & Related Disorders20240 iqtibos

   ABIABI:AkademIndex/2024.article.005940

7. Vascular remodeling in patients with CKD as a risk factor for the development of vascular Parkinsonism

   Sevara Khudayarova, G. Rakhmatullayeva, Bahtigul Holmuratova

   MaqolaNeurological Disorders and TreatmentsParkinsonism & Related Disorders20240 iqtibos

   ABIABI:AkademIndex/2024.article.005947

8. Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease

   Sevara Khudayarova, G.K. Rakhmatullayeva

   MaqolaDialysis and Renal Disease ManagementParkinsonism & Related Disorders20250 iqtibos

   ABIABI:AkademIndex/2025.article.004731

9. Efficacy of ocrelizumab in primary progressive multiple sclerosis

   Sevara Khudayarova, Gulnara Rakhmatullayeva

   MaqolaMultiple Sclerosis Research StudiesJournal of the Neurological Sciences20250 iqtibos

   ABIABI:AkademIndex/2025.article.018144